HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Therapeutic effect of defibrase in chronic glomerulonephritis with chronic renal failure].

Abstract
When chronic glomerulonephritis (CGN) proceeds to chronic renal failure (CRF), there are decline of fibrinolytic activity and deposition of fibrin in glomeruli with resulting thromboembolic lesions. 46 CGN patients with complicating CRF were thus treated with defibrase made from viper venom. Defibrase in a dose of 0.025 unit/kg dissolved in 250 ml 10% glucose was infused slowly once every 3 days in a total of 6 times. After the treatment, BUN and serum creatinine levels decreased, creatinine cleance improved and the clinical manifestations of uremia alleviated or disappeared. In some patients there were increase of hemoglobin concentration and decrease of urinary protein excretion. Hypertension was controlled in 17 out of 20 patients treated in combination with captopril. Level of plasma fibrinogen was significantly reduced after defibrase administration, but the reduction was not related to the therapeutic effect. Urinary output was increased in most of the patients, being related to the therapeutic effect. The authors are of the opinion that renal function may be improved in CGN patients after defibrase treatment due probably to elimination of fibrin deposition and resolution of thromboembolic lesions in glomeruli. However, a suitable dose has to be determined as there is no effective way to monitor the most dreaded complication of defibrase therapy bleeding.
AuthorsJ F Wu, S H Wang
JournalZhonghua nei ke za zhi (Zhonghua Nei Ke Za Zhi) Vol. 28 Issue 3 Pg. 171-3, 188 (Mar 1989) ISSN: 0578-1426 [Print] China
PMID2805953 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Batroxobin
  • Serine Endopeptidases
Topics
  • Adolescent
  • Adult
  • Batroxobin (therapeutic use)
  • Blood Urea Nitrogen
  • Child
  • Chronic Disease
  • Female
  • Glomerulonephritis (complications, drug therapy)
  • Humans
  • Kidney Failure, Chronic (drug therapy, etiology)
  • Male
  • Middle Aged
  • Serine Endopeptidases (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: